Interventional Treatment of Pulmonary Embolism

Circulation: Cardiovascular Interventions

Volumn 10, Issue 2, 2017, Pages

  Dudzinski, David M ^a   Giri, Jay ^b   Rosenfield, Kenneth ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

catheter; percutaneous; pulmonary embolism; team based care; thrombolysis

Indexed keywords

ANTICOAGULANT THERAPY; ARTICLE; ASSISTED CIRCULATION; BLOOD CLOT LYSIS; CARDIOPULMONARY BYPASS CANNULA; DEVICE COMPARISON; EMBOLECTOMY; FIBRINOLYSIS; FLUSH CATHETER; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LUNG EMBOLISM; MECHANICAL THROMBECTOMY; MEDICAL STAFF; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; RHEOLYTIC THROMBECTOMY; RISK ASSESSMENT; THROMBECTOMY CATHETER; THROMBUS ASPIRATION; VENA CAVA FILTER; CLINICAL DECISION MAKING; DIAGNOSTIC IMAGING; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; INTERVENTIONAL RADIOLOGY; MORTALITY; PATIENT CARE; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; PULMONARY EMBOLISM; RISK FACTOR; THROMBECTOMY; TREATMENT OUTCOME;

FIBRINOLYTIC AGENT;

CLINICAL DECISION-MAKING; EMBOLECTOMY; ENDOVASCULAR PROCEDURES; FIBRINOLYTIC AGENTS; HUMANS; PATIENT CARE TEAM; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PULMONARY EMBOLISM; RADIOGRAPHY, INTERVENTIONAL; RISK FACTORS; THROMBECTOMY; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VENA CAVA FILTERS;

EID: 85013471857     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.116.004345     Document Type: Article

References (75)

1. Provias T, Dudzinski DM, Jaff MR, Rosenfield K, Channick R, Baker J, Weinberg I, Donaldson C, Narayan R, Rassi AN, Kabrhel C. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract (1995). 2014;42:31-37. doi: 10.3810/hp.2014.02.1089
2. Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, Zierler BK; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: A scientific statement from the American Heart Association. Circulation. 2011;123:1788-1830. doi: 10.1161/CIR.0b013e318214914f
3. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149:315-352. doi: 10.1016/j.chest.2015.11.026
4. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033-3069, 3069a. doi: 10.1093/eurheartj/ehu283
5. Abrahams-van Doorn PJ, Hartmann IJ. Cardiothoracic CT: one-stop-shop procedure Impact on the management of acute pulmonary embolism. Insights Imaging. 2011;2:705-715. doi: 10.1007/s13244-011-0123-2
6. Konstantinides SV, Barco S, Lankeit M, Meyer G. Management of pulmonary embolism: An update. J Am Coll Cardiol. 2016;67:976-990. doi: 10.1016/j.jacc.2015.11.061
7. Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170:1383-1389. doi: 10.1001/archinternmed.2010.199
8. Meinel FG, Nance JW Jr, Schoepf UJ, Hoffmann VS, Thierfelder KM, Costello P, Goldhaber SZ, Bamberg F. Predictive value of computed tomography in acute pulmonary embolism: systematic review and meta-analysis. Am J Med. 2015;128:747-759.e2. doi: 10.1016/j. amjmed.2015.01.023
9. Hariharan P, Dudzinski DM, Rosovsky R, Haddad F, MacMahon P, Parry B, Chang Y, Kabrhel C. Relation among clot burden, right-sided heart strain, and adverse events after acute pulmonary embolism. Am J Cardiol. 2016;118:1568-1573. doi: 10.1016/j.amjcard.2016.08.025
10. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685-713, quiz 786. doi: 10.1016/j.echo.2010.05.010
11. Dudzinski DM, Hariharan P, Parry BA, Chang Y, Kabrhel C. Assessment of right ventricular strain by computed tomography versus echocardiography in acute pulmonary embolism [published online ahead of print September 24, 2016]. Acad Emerg Med. doi: 10.1111/acem.13108
12. Hariharan P, Dudzinski DM, Okechukwu I, Takayesu JK, Chang Y, Kabrhel C. Association between electrocardiographic findings, right heart strain, and short-term adverse clinical events in patients with acute pulmonary embolism. Clin Cardiol. 2015;38:236-242. doi: 10.1002/clc.22383
13. Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galiè N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV; PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370:1402-1411. doi: 10.1056/NEJMoa1302097
14. Reza N, Dudzinski DM. Pulmonary embolism response teams. Curr Treat Options Cardiovasc Med. 2015;17:387. doi: 10.1007/s11936-015-0387-9
15. Dudzinski DM, Piazza G. Multidisciplinary Pulmonary Embolism Response Teams. Circulation. 2016;133:98-103. doi: 10.1161/CIRCULATIONAHA.115.015086
16. Kabrhel C, Rempell JS, Avery LL, Dudzinski DM, Weinberg I. Case records of the Massachusetts General Hospital. Case 29-2014. A 60-year-old woman with syncope. N Engl J Med. 2014;371:1143-1150. doi: 10.1056/NEJMcpc1403307
17. Nakamura K, Alba GA, Scheske JA, Meyersohn NM, Stone JR, Vlahakes GJ, Wright CD, Ghoshhajra BB, Dudzinski DM. A 57-year-old man with insidious dyspnea and nonpleuritic chest and back pain. Chest. 2016;150:e41-e47. doi: 10.1016/j.chest.2016.02.680
18. Jiménez D, de Miguel-Díez J, Guijarro R, Trujillo-Santos J, Otero R, Barba R, Muriel A, Meyer G, Yusen RD, Monreal M; RIETE Investigators. Trends in the management and outcomes of acute pulmonary embolism: Analysis from the RIETE Registry. J Am Coll Cardiol. 2016;67:162-170. doi: 10.1016/j.jacc.2015.10.060
19. Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Massive pulmonary embolism. Circulation. 2006;113:577-582. doi: 10.1161/CIRCULATIONAHA.105.592592
20. Grifoni S, Olivotto I, Cecchini P, Pieralli F, Camaiti A, Santoro G, Conti A, Agnelli G, Berni G. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000;101:2817-2822
21. Jaber WA, Fong PP, Weisz G, Lattouf O, Jenkins J, Rosenfield K, Rab T, Ramee S. Acute pulmonary embolism: with an emphasis on an interventional approach. J Am Coll Cardiol. 2016;67:991-1002. doi: 10.1016/j. jacc.2015.12.024
22. Dudzinski DM, Horowitz JM. Start-up, Organization and Performance of a Multidisciplinary Pulmonary Embolism Response Team for the Diagnosis and Treatment of Acute Pulmonary Embolism. Rev Esp Cardiol (Engl Ed). 2017;70:9-13. doi: 10.1016/j.rec.2016.05.025
23. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947. doi: 10.1161/STR.0b013e318284056a
24. Holmes DR Jr, Rich JB, Zoghbi WA, Mack MJ. The heart team of cardiovascular care. J Am Coll Cardiol. 2013;61:903-907. doi: 10.1016/j. jacc.2012.08.1034
25. Kline JA, Steuerwald MT, Marchick MR, Hernandez-Nino J, Rose GA. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. Chest. 2009;136:1202-1210. doi: 10.1378/chest.08-2988
26. Konstantinides S, Tiede N, Geibel A, Olschewski M, Just H, Kasper W. Comparison of alteplase versus heparin for resolution of major pulmonary embolism. Am J Cardiol. 1998;82:966-970
27. Becattini C, Agnelli G, Salvi A, Grifoni S, Pancaldi LG, Enea I, Balsemin F, Campanini M, Ghirarduzzi A, Casazza F; TIPES Study Group. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thromb Res. 2010;125:e82-e86. doi: 10.1016/j.thromres.2009.09.017
28. Abu-Laban RB, Christenson JM, Innes GD, van Beek CA, Wanger KP, McKnight RD, MacPhail IA, Puskaric J, Sadowski RP, Singer J, Schechter MT, Wood VM. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med. 2002;346:1522-1528. doi: 10.1056/NEJMoa012885
29. Sharifi M, Berger J, Beeston P, Bay C, Vajo Z, Javadpoor S; "PEAPETT" investigators. Pulseless electrical activity in pulmonary embolism treated with thrombolysis (from the "PEAPETT" study). Am J Emerg Med. 2016;34:1963-1967. doi: 10.1016/j.ajem.2016.06.094
30. Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P, Kumbhani DJ, Mukherjee D, Jaff MR, Giri J. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: A meta-analysis. JAMA. 2014;311:2414-2421. doi: 10.1001/jama.2014.5990
31. Chatterjee S, Lip GY, Giri J. HAS-BLED versus ATRIA risk scores for intracranial hemorrhage in patients receiving thrombolytics for pulmonary embolism. J Am Coll Cardiol. 2016;67:2904-2905. doi: 10.1016/j. jacc.2016.03.577
32. Stein PD, Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med. 2012;125:465-470. doi: 10.1016/j.amjmed.2011.10.015
33. Pollack CV, Schreiber D, Goldhaber SZ, Slattery D, Fanikos J, O'Neil BJ, Thompson JR, Hiestand B, Briese BA, Pendleton RC, Miller CD, Kline JA. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol. 2011;57:700-706. doi: 10.1016/j.jacc.2010.05.071
34. Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M; "MOPETT" Investigators. Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial). Am J Cardiol. 2013;111:273-277. doi: 10.1016/j.amjcard.2012.09.027
35. Diamond SL, Anand S. Inner clot diffusion and permeation during fibrinolysis. Biophys J. 1993;65:2622-2643. doi: 10.1016/S0006-3495(93)81314-6
36. Blinc A, Kennedy SD, Bryant RG, Marder VJ, Francis CW. Flow through clots determines the rate and pattern of fibrinolysis. Thromb Haemost. 1994;71:230-235
37. Schmitz-Rode T, Kilbinger M, Günther RW. Simulated flow pattern in massive pulmonary embolism: significance for selective intrapulmonary thrombolysis. Cardiovasc Intervent Radiol. 1998;21:199-204
38. González-Juanatey JR, Valdés L, Amaro A, Iglesias C, Alvarez D, García Acuña JM, de la Peña MG. Treatment of massive pulmonary thromboembolism with low intrapulmonary dosages of urokinase. Short-term angiographic and hemodynamic evolution. Chest. 1992;102:341-346
39. Verstraete M, Miller GA, Bounameaux H, Charbonnier B, Colle JP, Lecorf G, Marbet GA, Mombaerts P, Olsson CG. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation. 1988;77:353-360
40. Braaten JV, Goss RA, Francis CW. Ultrasound reversibly disaggregates fibrin fibers. Thromb Haemost. 1997;78:1063-1068
41. Kucher N, Boekstegers P, Müller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T, Tebbe U, Horstkotte J, Müller R, Blessing E, Greif M, Lange P, Hoffmann RT, Werth S, Barmeyer A, Härtel D, Grünwald H, Empen K, Baumgartner I. Randomized, controlled trial of ultrasoundassisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014;129:479-486. doi: 10.1161/CIRCULATIONAHA.113.005544
42. Piazza G, Hohlfelder B, Jaff MR, Ouriel K, Engelhardt TC, Sterling KM, Jones NJ, Gurley JC, Bhatheja R, Kennedy RJ, Goswami N, Natarajan K, Rundback J, Sadiq IR, Liu SK, Bhalla N, Raja ML, Weinstock BS, Cynamon J, Elmasri FF, Garcia MJ, Kumar M, Ayerdi J, Soukas P, Kuo W, Liu PY, Goldhaber SZ; SEATTLE II Investigators. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. JACC Cardiovasc Interv. 2015;8:1382-1392. doi: 10.1016/j.jcin.2015.04.020
43. Engelberger RP, Spirk D, Willenberg T, Alatri A, Do DD, Baumgartner I, Kucher N. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv. 2015;8.e002027
44. Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hofmann LV. Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol. 2009;20:1431-1440. doi: 10.1016/j.jvir.2009.08.002
45. Kuo WT, Banerjee A, Kim PS, DeMarco FJ Jr, Levy JR, Facchini FR, Unver K, Bertini MJ, Sista AK, Hall MJ, Rosenberg JK, De Gregorio MA. Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): initial results from a prospective multicenter registry. Chest. 2015;148:667-673. doi: 10.1378/chest.15-0119
46. Nakazawa K, Tajima H, Murata S, Kumita SI, Yamamoto T, Tanaka K. Catheter fragmentation of acute massive pulmonary thromboembolism: distal embolisation and pulmonary arterial pressure elevation. Br J Radiol. 2008;81:848-854. doi: 10.1259/bjr/93840362
47. Kumar N, Janjigian Y, Schwartz DR. Paradoxical worsening of shock after the use of a percutaneous mechanical thrombectomy device in a postpartum patient with a massive pulmonary embolism. Chest. 2007;132:677-679. doi: 10.1378/chest.06-1082
48. Ierardi AM, Xhepa G, Piffaretti G, Bacuzzi A, Tozzi M, Carbone M, Barile A, Squillaci E, Fonio P, Brunese L, Carrafiello G. Clinical experience with AngioJet: A comprehensive review. Int Angiol. 2015;34(6 suppl 1):1-14
49. Chechi T, Vecchio S, Spaziani G, Giuliani G, Giannotti F, Arcangeli C, Rubboli A, Margheri M. Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism. Catheter Cardiovasc Interv. 2009;73:506-513. doi: 10.1002/ccd.21858
50. Bonvini RF, Roffi M, Bounameaux H, Noble S, Müller H, Keller PF, Jolliet P, Sarasin FP, Rutschmann OT, Bendjelid K, Righini M. AngioJet rheolytic thrombectomy in patients presenting with high-risk pulmonary embolism and cardiogenic shock: A feasibility pilot study. EuroIntervention. 2013;8:1419-1427. doi: 10.4244/EIJV8I12A215
51. Lin PH, Okada T, Steinberg JL, Zhou W, El Sayed HF, Rawat A, Kougias P, Yao Q, Chen C. Rheolytic pharmacomechanical thrombectomy in experimental chronic deep vein thrombosis: effect of L-arginine on thrombogenicity and endothelial vasomotor function. World J Surg. 2007;31:664-675. doi: 10.1007/s00268-007-0733-5
52. Zhu DW. The potential mechanisms of bradyarrhythmias associated with AngioJet thrombectomy. J Invasive Cardiol. 2008;20(8 suppl A):2A-4A
53. Dumantepe M, Teymen B, Akturk U, Seren M. Efficacy of rotational thrombectomy on the mortality of patients with massive and submassive pulmonary embolism. J Card Surg. 2015;30:324-332. doi: 10.1111/jocs.12521
54. Bayiz H, Dumantepe M, Teymen B, Uyar I. Percutaneous aspiration thrombectomy in treatment of massive pulmonary embolism. Heart Lung Circ. 2015;24:46-54. doi: 10.1016/j.hlc.2014.06.014
55. Benenati J, Saxon R, Teigen C, Adams G. Penumbra/Indigo System provides a novel aspiration thrombectomy tool in treatment of peripheral and visceral arterial occlusions: final results of the PRISM trial. Society of Interventional Radiology Scientific Sessions. J Vasc Interv Radiol. 2016;27:S96
56. Donaldson CW, Baker JN, Narayan RL, Provias TS, Rassi AN, Giri JS, Sakhuja R, Weinberg I, Jaff MR, Rosenfield K. Thrombectomy using suction filtration and veno-venous bypass: single center experience with a novel device. Catheter Cardiovasc Interv. 2015;86:E81-E87. doi: 10.1002/ccd.25583
57. Moriarty JM, Al-Hakim R, Bansal A, Park JK. Removal of caval and right atrial thrombi and masses using the AngioVac device: initial operative experience. J Vasc Interv Radiol. 2016;27:1584-1591. doi: 10.1016/j.jvir.2016.03.045
58. Goldhaber SZ. Surgical pulmonary embolectomy: the resurrection of an almost discarded operation. Tex Heart Inst J. 2013;40:5-8
59. Leacche M, Unic D, Goldhaber SZ, Rawn JD, Aranki SF, Couper GS, Mihaljevic T, Rizzo RJ, Cohn LH, Aklog L, Byrne JG. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg. 2005;129:1018-1023. doi: 10.1016/j. jtcvs.2004.10.023
60. Fukuda I, Taniguchi S, Fukui K, Minakawa M, Daitoku K, Suzuki Y. Improved outcome of surgical pulmonary embolectomy by aggressive intervention for critically ill patients. Ann Thorac Surg. 2011;91:728-732. doi: 10.1016/j.athoracsur.2010.10.086
61. Zarrabi K, Zolghadrasli A, Ostovan MA, Azimifar A. Short-term results of retrograde pulmonary embolectomy in massive and submassive pulmonary embolism: A single-center study of 30 patients. Eur J Cardiothorac Surg. 2011;40:890-893. doi: 10.1016/j. ejcts.2011.06.004
62. Keeling WB, Sundt T, Leacche M, Okita Y, Binongo J, Lasajanak Y, Aklog L, Lattouf OM; SPEAR Working Group. Outcomes after surgical pulmonary embolectomy for acute pulmonary embolus: A multi-institutional study. Ann Thorac Surg. 2016;102:1498-1502. doi: 10.1016/j. athoracsur.2016.05.004
63. Hartman AR, Manetta F, Lessen R, Pekmezaris R, Kozikowski A, Jahn L, Akerman M, Lesser ML, Glassman LR, Graver M, Scheinerman JS, Kalimi R, Palazzo R, Vatsia S, Pogo G, Hall M, Yu PJ, Singh V. Acute surgical pulmonary embolectomy: A 9-year retrospective analysis. Tex Heart Inst J. 2015;42:25-29. doi: 10.14503/THIJ-13-3877
64. Kaufman JA, Kinney TB, Streiff MB, Sing RF, Proctor MC, Becker D, Cipolle M, Comerota AJ, Millward SF, Rogers FB, Sacks D, Venbrux AC. Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference. J Vasc Interv Radiol. 2006;17:449-459
65. Stein PD, Matta F, Hull RD. Increasing use of vena cava filters for prevention of pulmonary embolism. Am J Med. 2011;124:655-661. doi: 10.1016/j.amjmed.2011.02.021
66. Duszak R Jr, Parker L, Levin DC, Rao VM. Placement and removal of inferior vena cava filters: national trends in the medicare population. J Am Coll Radiol. 2011;8:483-489. doi: 10.1016/j.jacr.2010.12.021
67. Girard TD, Philbrick JT, Fritz Angle J, Becker DM. Prophylactic vena cava filters for trauma patients: A systematic review of the literature. Thromb Res. 2003;112:261-267. doi: 10.1016/j.thromres.2003.12.004
68. Kim HS, Young MJ, Narayan AK, Hong K, Liddell RP, Streiff MB. A comparison of clinical outcomes with retrievable and permanent inferior vena cava filters. J Vasc Interv Radiol. 2008;19:393-399. doi: 10.1016/j. jvir.2007.09.019
69. Smoot RL, Koch CA, Heller SF, Sabater EA, Cullinane DC, Bannon MP, Thomsen KM, Harmsen WS, Baerga-Varela Y, Schiller HJ. Inferior vena cava filters in trauma patients: efficacy, morbidity, and retrievability. J Trauma. 2010;68:899-903. doi: 10.1097/TA.0b013e3181d3cbdc
70. Abtahian F, Hawkins BM, Ryan DP, Cefalo P, Nasser NJ, MacKay C, Jaff MR, Weinberg I. Inferior vena cava filter usage, complications, and retrieval rate in cancer patients. Am J Med. 2014;127:1111-1117. doi: 10.1016/j.amjmed.2014.06.025
71. Removing Retrievable Inferior Vena Cava Filters: FDA Safety Communication. 2014. http://www.fda.gov/MedicalDevices/Safety/Alerts andNotices/ucm396377.htm. Accessed February 5, 2017
72. Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, Laporte S, Faivre R, Charbonnier B, Barral FG, Huet Y, Simonneau G. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998;338:409-415. doi: 10.1056/NEJM199802123380701
73. Mismetti P, Laporte S, Pellerin O, Ennezat PV, Couturaud F, Elias A, Falvo N, Meneveau N, Quere I, Roy PM, Sanchez O, Schmidt J, Seinturier C, Sevestre MA, Beregi JP, Tardy B, Lacroix P, Presles E, Leizorovicz A, Decousus H, Barral FG, Meyer G; PREPIC2 Study Group. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: A randomized clinical trial. JAMA. 2015;313:1627-1635. doi: 10.1001/jama.2015.3780
74. Carroll BJ, Shah RV, Murthy V, McCullough SA, Reza N, Thomas SS, Song TH, Newton-Cheh CH, Camuso JM, MacGillivray T, Sundt TM, Semigran MJ, Lewis GD, Baker JN, Garcia JP. Clinical features and outcomes in adults with cardiogenic shock supported by extracorporeal membrane oxygenation. Am J Cardiol. 2015;116:1624-1630. doi: 10.1016/j.amjcard.2015.08.030
75. Anderson MB, Goldstein J, Milano C, Morris LD, Kormos RL, Bhama J, Kapur NK, Bansal A, Garcia J, Baker JN, Silvestry S, Holman WL, Douglas PS, O'Neill W. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant. 2015;34:1549-1560. doi: 10.1016/j.healun.2015.08.018.